|
KIAA0406 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.869900E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.435600E-01 |
| Normal-vs-Stage2 |
4.277600E-01 |
| Normal-vs-Stage3 |
1.228160E-01 |
| Normal-vs-Stage4 |
2.428600E-01 |
| Stage1-vs-Stage2 |
5.744200E-01 |
| Stage1-vs-Stage3 |
1.603810E-01 |
| Stage1-vs-Stage4 |
3.166600E-01 |
| Stage2-vs-Stage3 |
6.387200E-01 |
| Stage2-vs-Stage4 |
1.674050E-01 |
| Stage3-vs-Stage4 |
4.324400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.544100E-02 |
| Normal-vs-AfricanAmerican |
7.543600E-01 |
| Normal-vs-Asian |
9.986600E-01 |
| Caucasian-vs-AfricanAmerican |
5.061800E-02 |
| Caucasian-vs-Asian |
6.248200E-01 |
| AfricanAmerican-vs-Asian |
9.122400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.582000E-01 |
| Normal-vs-Female |
1.071970E-02 |
| Male-vs-Female |
6.030400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.897400E-01 |
| Normal-vs-Extreme_Weight |
7.009600E-01 |
| Normal-vs-Obese |
3.887900E-02 |
| Normal-vs-Extreme_Obese |
2.673600E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.204600E-01 |
| Normal_Weight-vs-Obese |
1.733250E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.541800E-01 |
| Extreme_Weight-vs-Obese |
3.539800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.315000E-01 |
| Obese-vs-Extreme_Obese |
1.103420E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.549700E-02 |
| Normal-vs-Age(41-60Yrs) |
9.055200E-03 |
| Normal-vs-Age(61-80Yrs) |
5.456200E-01 |
| Normal-vs-Age(81-100Yrs) |
3.302200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.374800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.122400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.861900E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.689700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.239010E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.911620E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.512200E-02 |
| Normal-VS-Type2 PRCC |
3.768200E-01 |
| Normal-VS-KIRP CIMP |
5.115800E-01 |
| Normal-VS-Unclassified PRCC |
8.379700E-03 |
| Type1 PRCC-VS-Type2 PRCC |
2.642400E-02 |
| Type1 PRCC-VS-KIRP CIMP |
9.168800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.791900E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.060200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.939100E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
3.155200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.805400E-01 |
| Normal-vs-N1 |
1.429190E-01 |
| Normal-vs-N2 |
4.856000E-01 |
| N0-vs-N1 |
1.570210E-01 |
| N0-vs-N2 |
8.359800E-01 |
| N1-vs-N2 |
4.014600E-01 |
|
|
